Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France

Autor:	Tremblay, Gabriel, Cariou, Clemence, Recher, Christian, Dolph, Mike, Brandt, Patricia, Blanc, Anne-Sandrine, Forsythe, Anna
Zdroj:	The European Journal of Health Economics, 2020 Jun 01. 21(4), 543-555.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/45287025 Zobrazit plný text záznamu Full text from SpringerLink